drugset / Trial / NCT00564226
SSR240600C Treatment in Women With Overactive Bladder
RandomizedParallel-groupDouble-blindTreatment
Summary
The primary objective of this study is to evaluate the efficacy of SSR240600C in women with overactive bladder compared to placebo using tolterodine as a study calibrator.
Timeline
- Start
- 2007-11
- Primary completion
- 2009-02
- Completion
- 2009-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BURAPITANT | Small molecule | — | Oral |
| Comparator | Tolterodine | Small molecule | — | Oral |